TrialNature medicine2025

Angiogenic factors versus fetomaternal Doppler for fetal growth restriction at term: an open-label, randomized controlled trial.

Pablo Garcia-Manau et al.PubMed ↗Publisher ↗

No numbers read from the abstract.